The management of asthmatic smokers

José Miguel Chatkin, Cynthia Rocha Dullius, José Miguel Chatkin, Cynthia Rocha Dullius

Abstract

Asthma is still a major public health problem in most countries; new strategies to better control this disease are necessary. Such strategies must include predisposing factors. One of these factors is smoking and a significant fraction of asthmatics are smokers. However, clinical trials studying new drugs or newer therapeutic regimens for asthma generally exclude smokers. Therefore, there is a lack of specific information about the treatment of asthma in smokers. The asthmatic smoker is a special phenotype with important therapeutic and prognostic clinical implications. Any form of tobacco use, especially cigarette smoking, plays an important role in this disease. Asthmatic smokers are prone to several negative outcomes. Smoking cessation results in an improvement of symptoms and pulmonary functioning. Counselling and first-line medications for smoking cessation (nicotine replacement therapy, bupropion and varenicline) significantly increase quitting rates. The role of electronic cigarettes in this group of patients has only begun to be studied. The treatment of asthmatics that smoke has characteristics that need must be well understood by clinicians, especially the poor response to corticosteroids. This condition is not universal and physicians should always consider its inclusion in the treatment of these patients. The association of inhaled corticosteroids (ICS) plus a long-acting beta2 adrenegic (LABA) by smoking asthmatics results in more pronounced improvement in several asthma outcomes compared with the use of corticosteroid alone. Inhaled corticosteroids in extra-fine particles associated with LABA may be a new perspective of treatment. Also the use of leukotriene antagonists may become another therapeutic alternative. The purpose of this narrative review is to discuss the challenges faced by clinicians to control asthma in smokers and to present methods of coping with smoking treatment and avoiding relapses.

Keywords: Anti asthmatic agents; Asthma; Smoking; Smoking cessation.

References

    1. Global Initiative for Asthma. Global strategy for asthma management and prevention 2015 revision. Accessed Feb 2, 2016. 2015.
    1. Olin JT, Wechsler ME. Asthma: pathogenesis and novel drugs for treatment. BMJ. 2014;349:g5517. doi: 10.1136/bmj.g5517.
    1. Sears MR. Smoking, asthma, chronic airflow obstruction and COPD. Eur Respir J. 2015;45(3):586–8. doi: 10.1183/09031936.00231414.
    1. Bakakos P, Kostikas K, Loukides S. Smoking asthma phenotype: diagnostic and management challenges. Curr Opin Pulm Med. 2016;22(1):53–8. doi: 10.1097/MCP.0000000000000221.
    1. Jiménez-Ruiz CA, Andreas S, Lewis KE, Tonnesen P, van Schayck CP, Hajek P, et al. ERS Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J. 2015;46(1):61–79. doi: 10.1183/09031936.00092614.
    1. Cerveri I, Cazzoletti L, Corsico AG, et al. The impact of cigarette smoking on asthma: a population based international cohort study. Allergy Immunology. 2012;158(2):175–83. doi: 10.1159/000330900.
    1. Moazed F, Calfee CS. Clearing the air. Smoking and incident asthma in adults. Am J Respir Crit Care Med. 2015;191(2):123–4. doi: 10.1164/rccm.201411-2098ED.
    1. Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J. 2013;41:716–26. doi: 10.1183/09031936.00073312.
    1. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. The health consequences of smoking: 50 years of progress. A report of the Surgeon General. 2014.
    1. Aanerud M, Carsin AE, Sunyer J, Dratva J, Gislason T, deMarco R, et al. Interaction between asthma and smoking increases the risk of adult airway obstruction. Eur Respir J. 2015;45(3):635–43. doi: 10.1183/09031936.00055514.
    1. Coogan PF, Castro-Webb N, Yu J, O’Connor GT, Palmer JR, Rosenberg L. Active and passive smoking and the incidence of asthma in the Black Women’s Health Study. Am J Respir Crit Care Med. 2015;191(2):168–76. doi: 10.1164/rccm.201406-1108OC.
    1. Apostol GG, Jacobs DR, Jr, Tsai AW, Crow RS, Williams OD, Townsend MC, et al. Early life factors contribute to the decrease in lung function between ages 18 and 40: the Coronary Artery Risk Development in Young Adults study. Am J Respir Crit Care Med. 2002;166(2):166–72. doi: 10.1164/rccm.2007035.
    1. Polosa R, Caponnetto P, Sands MF. Caring for the smoking asthmatic patient. J Allergy Clin Immunol. 2012;130:1221–4. doi: 10.1016/j.jaci.2012.04.015.
    1. Price D, Bjermer L, Popov TA, Chisholm A. Integrating Evidence for Managing Asthma in Patients Who Smoke. Allergy, Asthma Immunol Res. 2014;6(2):114–20. doi: 10.4168/aair.2014.6.2.114.
    1. Thomson NC, Spears M. Asthma guidelines and smoking: it’s time to be inclusive. Chest. 2012;141:286–8. doi: 10.1378/chest.11-1424.
    1. Eisner MD, Iribarren C. The influence of cigarette smoking on adult asthma outcomes. Nicotine Tob Res. 2007;9:53–6. doi: 10.1080/14622200601078293.
    1. Chalmers GW, MacLeod KJ, Thomson L, Little SA, McSharry C, Thomson NC. Smoking and airway inflammation in patients with mild asthma. Chest. 2001;120:1917–22. doi: 10.1378/chest.120.6.1917.
    1. Chaudhuri R, Livingston E, McMahon AD, Lafferty J, Fraser I, Spears M, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med. 2006;174:127–33. doi: 10.1164/rccm.200510-1589OC.
    1. Lazarus SC, Chinchilli VM, Rollings NJ, Boushey HA, Cherniak R, Craig TJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med. 2007;175:783–90. doi: 10.1164/rccm.200511-1746OC.
    1. O’Byrne PM, Lamm CJ, Busse WW, Tan WC, Pedersen S, START Investigators Group The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. Chest. 2009;136(6):1514–20. doi: 10.1378/chest.09-1049.
    1. Pedersen SE, Bateman ED, Bousquet J, Busse WW, Yoxall S, Clark TJ. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma Control study. J Allergy Clin Immunol. 2007;120:1036–42. doi: 10.1016/j.jaci.2007.07.016.
    1. Polosa R, Knoke JD, Russo C, Piccillo G, Caponnetto P, Sarvà M, et al. Cigarette smoking is associated with a greater risk of incident asthma in allergic rhinitis. J Allergy Clin Immunol. 2008;121:1428–34. doi: 10.1016/j.jaci.2008.02.041.
    1. Polosa R, Russo C, Caponnetto P, Bertino G, Sarvà M, Antic T, et al. Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study. Respir Res. 2011;12:16–26. doi: 10.1186/1465-9921-12-16.
    1. Silverman RA, Boudreaux ED, Woodruff PG, Clark S, Camargo CA. Cigarette smoking among asthmatic adults presenting to 64 emergency departments. Chest. 2003;123(5):1472–9. doi: 10.1378/chest.123.5.1472.
    1. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med. 2003;168(11):1308–11. doi: 10.1164/rccm.200304-503OC.
    1. Thomson N, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med. 2009;15:39–45. doi: 10.1097/MCP.0b013e32831da894.
    1. Thomson NC, Chaudhuri R, Heaney LG, Bucknall C, Niven RM, Brightling CE, et al. Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma. J Allergy Clin Immunol. 2013;131(4):1008–16. doi: 10.1016/j.jaci.2012.12.1574.
    1. St-Laurent J, Bergeron C, Pagé N, Couture C, Laviolette M, Boulet LP. The influence of smoking on airway inflammation and remodelling in asthma. Clin Exp Allergy. 2008;38(10):1582–9. doi: 10.1111/j.1365-2222.2008.03032.x.
    1. Thomson NC, Chaudhuri R, Spears M, Messow CM, MacNee W, Connell M, et al. Poor symptom control is associated with reduced CT segmental airway lumen area inasthmatic smokers. Chest. 2015;147(3):735–44. doi: 10.1378/chest.14-1119.
    1. Comhair SA, Gaston BM, Ricci KS, Hammel J, Dweik RA, Teague WG, et al. Detrimental effects of environmental tobacco smoke in relation to asthma severity. PLoS One. 2011;6(5):e18574. doi: 10.1371/journal.pone.0018574.
    1. Silvestri M, Franchi S, Pistorio A, Petecchia L, Rusconi F. Smoke exposure, wheezing, and asthma development: a systematic review and meta-analysis in unselected birth cohorts. Pediatr Pulmonol. 2015;50(4):353–62. doi: 10.1002/ppul.23037.
    1. Burke H, Leonardi-Bee J, Hashim A. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics. 2012;129(4):735–44. doi: 10.1542/peds.2011-2196.
    1. Farber HJ. Harm of in utero tobacco smoke exposure: a heritable trait? Chest. 2014;145(6):1182–4. doi: 10.1378/chest.13-2868.
    1. Werhmeister FC, Nunes BP, Mola CL, Gómez-Cofré N, Oliveira PD, Marco PL, et al. Intrauterine exposure to smoking and wheezing in adolescence: the 1993 Pelotas Birth Cohort. J Dev Orig Health Dis. 2014;18:1–8.
    1. Li YF, Langholz B, Salam MT, Gilliland FD. Maternal and grandmaternal smoking patterns are associated with early childhood asthma. Chest. 2005;127(4):1232–41.
    1. Magnus MC, Håberg SE, Karlstad Ø, Nafstad P, London SJ, Nystad W. Grandmother’s smoking when pregnant with the mother and asthma in the grandchild: the Norwegian Mother and Child Cohort Study. Thorax. 2015;70(3):237–43. doi: 10.1136/thoraxjnl-2014-206438.
    1. Leslie FM. Multigenerational epigenetic effects of nicotine on lung function. BMC Med. 2013;11(27):1–4.
    1. Farber HJ, Batsell RR, Silveira EA, Calhoun RT, Giardino AP. The Impact of Tobacco Smoke Exposure on Childhood Asthma in a Medicaid Managed Care Plan. Chest. 2016;149(3):721-8.
    1. Piccillo G, Caponnetto P, Barton S, Russo C, Origlio A, Bonaccorsi A, et al. Changes in airway hyperresponsiveness following smoking cessation: comparisons between Mch and AMP. Respir Med. 2008;102:256–65. doi: 10.1016/j.rmed.2007.09.004.
    1. Tonnesen P, Pisinger C, Hvidberg S, Wennike P, Bremann L, Westin A, et al. Effects of smoking cessation and reduction in asthmatics. Nicotine Tob Res. 2005;7:139–48. doi: 10.1080/14622200412331328411.
    1. Hekking PPW, Bel EH. Developing and Emerging Clinical Asthma Phenotypes. J Allergy Clin Immunol Pract. 2014;2(6):671–80. doi: 10.1016/j.jaip.2014.09.007.
    1. Cruz AA. Asma e tabagismo (Asthma and Smoking) Pneumonews. 2015;5(4):4–11.
    1. Avallone KM, Kimberly M, McLeish AC, Zvolensky MJ, Kraemer KM, Luberto CM, et al. Asthma and its relation to smoking behavior and cessation motives among adult daily smokers. J Health Psychol. 2012;18(6):788–99. doi: 10.1177/1359105312456322.
    1. Spears M, Cameron E, Chaudhuri R, Thomson NC. Challenges of treating asthma in people who smoke. Expert Rev Clin Immunol. 2010;6(2):257–68. doi: 10.1586/eci.09.85.
    1. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339(17):1194–200. doi: 10.1056/NEJM199810223391703.
    1. Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 2002;57:226–30. doi: 10.1136/thorax.57.3.226.
    1. Polosa R, Morjaria J, Caponnetto P, Caruso M, Strano S, Battaglia E, et al. Effect of Smoking Abstinence and Reduction in Asthmatic Smokers Switching to Electronic Cigarettes: Evidence for Harm Reversal. Int J Environ Res Public Health. 2014;11:4965–77. doi: 10.3390/ijerph110504965.
    1. Tomlinson JEM, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax. 2005;60(4):282–7. doi: 10.1136/thx.2004.033688.
    1. Caponnetto P, Keller E, Bruno CM, Polosa R. Handling relapse in smoking cessation: strategies and recommendations. Intern Emerg Med. 2013;8:7–12. doi: 10.1007/s11739-012-0864-z.
    1. Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz N, Curry SJ et al. Treating tobacco use and dependence: 2008 update. Washington (DC): US Department ofHealth and Human Services, Public Health Service 2008.
    1. Westergaard CG, Porsbjerg C, Backer V. The effect of varenicline on smoking cessation in a group of young asthma patients. Respir Med. 2015;109(11):1416–22. doi: 10.1016/j.rmed.2015.07.017.
    1. Rigotti NA. Smoking cessation in patients with respiratory disease: existing treatments and future directions. Lancet Respir Med. 2013;1(3):241–50. doi: 10.1016/S2213-2600(13)70063-8.
    1. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;5:CD009329.
    1. Baker TB, Piper ME, Stein JH, Smith SS, Bolt DM, Fraser DL, et al. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial. JAMA. 2016;315(4):371–9. doi: 10.1001/jama.2015.19284.
    1. Cooke A, Fergeson J, Bulkhi A, Casale TB. The Electronic Cigarette: The Good, the Bad, and the Ugly. J Allergy Clin Immunol Pract. 2015;3(4):498–505. doi: 10.1016/j.jaip.2015.05.022.
    1. Thomson NC. Addressing corticosteroid insensitivity in adults with asthma. Expert Rev Respir Med 2015; [Epub ahead of print].
    1. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J. 2004;24:822–33. doi: 10.1183/09031936.04.00039004.
    1. Reddel HK, Bateman ED, Becker A, Boulet LP, Cruz A, Drazen JM, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 2015;46(3):622–39. doi: 10.1183/13993003.00853-2015.
    1. Clearie K, McKinlay L, Williamson P, Lipworth B. Fluticasone/salmeterol combination confers benefits in smoking asthmatics. Chest. 2012;141:330–8. doi: 10.1378/chest.11-0392.
    1. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthmacontrol be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med. 2004;170:836–44. doi: 10.1164/rccm.200401-033OC.
    1. Price D, Popov TA, Bjermer L, Lu S, Petrovic R, Vandormael K, et al. Effect of montelukast for treatment of asthma in cigarette smokers. J Allergy Clin Immunol. 2013;131:763–71. doi: 10.1016/j.jaci.2012.12.673.
    1. Ivancsó I, Böcskei R, Müller V, Tamási L. Extrafine inhaled corticosteroid therapy in the control of asthma. J Asthma Allergy. 2013;6:69–80.
    1. Brusselle G, Peché R, Van den Brande P, Verhulst A, Hollanders W, Bruhwyler J. Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status. Respir Med. 2012;106:811–9. doi: 10.1016/j.rmed.2012.01.010.
    1. Scichilone N, Benfante A, Morandi L, Bellini F, Papi A. Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD. Patient Related Outcome Measures. 2014;5:153–62.
    1. Spears M, Donnelly I, Jolly L, Brannigan M, Ito K, McSharry C, et al. Effect of low-dose theophylline plus beclomethasone on lung function in smokers with asthma: a pilot study. Eur Respir J. 2009;33(5):1010–7. doi: 10.1183/09031936.00158208.
    1. Thomson NC, Charron CE, Chaudhuri R, Spears M, Ito K, McSharry C. Atorvastatin in combination with inhaled beclometasone modulates inflammatory sputum mediators in smokers with asthma. Pulm Pharmacol Ther. 2015;31:1–8. doi: 10.1016/j.pupt.2015.01.001.
    1. Thomson NC, Chaudhuri R, Spears M, Messow CM, Jelinsky S, Miele G, et al. Arachidonic acid metabolites and enzyme transcripts in asthma are altered by cigarette smoking. Allergy. 2014;69:527–36. doi: 10.1111/all.12376.
    1. Pizzichini MM, Kerstjens HUM, Pizzichini E. Current role of anticholinergic drugs in the treatment of asthma: key messages for clinical practice. Pol Arch Med Wewn. 2015;125(11):859–66.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren